To the full analysis
Buyback calculator for Novavax
Novavax stock: key metrics
NVAXNovavax had an operating margin of 50.1% and a return on invested capital (ROIC) of 99.9% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | −38.2% | −525.5% | −492.6% |
| 2007 | 85.4% | −2,000.7% | −2,297.8% |
| 2008 | 100.0% | −3,229.3% | −3,388.1% |
| 2009 | 100.0% | −11,502.5% | −11,807.4% |
| 2010 | 100.0% | −11,222.7% | −10,410.5% |
| 2011 | 52.3% | −146.9% | −131.8% |
| 2012 | 33.4% | −134.4% | −129.1% |
| 2013 | 60.7% | −250.7% | −248.5% |
| 2014 | 51.1% | −273.0% | −270.5% |
| 2015 | −348.7% | −433.8% | −432.9% |
| 2016 | −1,449.8% | −1,752.8% | −1,823.5% |
| 2017 | 100.0% | −550.8% | −589.5% |
| 2018 | 100.0% | −507.2% | −538.8% |
| 2019 | −510.0% | −646.1% | −697.1% |
| 2020 | 100.0% | −1,861.3% | −1,868.2% |
| 2021 | 100.0% | −853.6% | −882.5% |
| 2022 | 43.5% | −40.3% | −41.1% |
| 2023 | 38.2% | −101.8% | −98.0% |
| 2024 | 70.3% | −36.5% | −27.5% |
| 2025 | 93.7% | 50.1% | 39.2% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | −24.5% | −44.6% | −18.9% |
| 2007 | −55.1% | −57.7% | −38.1% |
| 2008 | −79.2% | −73.5% | −47.0% |
| 2009 | −51.5% | −88.8% | −44.8% |
| 2010 | −60.5% | −42.7% | −47.7% |
| 2011 | −36.0% | −53.6% | −29.1% |
| 2012 | −35.5% | −64.0% | −27.9% |
| 2013 | −25.6% | −75.5% | −22.0% |
| 2014 | −36.1% | −98.0% | −30.1% |
| 2015 | −53.6% | −45.0% | −40.7% |
| 2016 | 200.0% | −66.7% | −71.0% |
| 2017 | 180.6% | −98.2% | −60.8% |
| 2018 | 110.0% | −70.2% | −88.8% |
| 2019 | 69.9% | −61.5% | −75.2% |
| 2020 | −66.7% | −57.3% | −26.4% |
| 2021 | 200.0% | no data | −67.7% |
| 2022 | 103.8% | no data | −29.1% |
| 2023 | 76.0% | no data | −30.3% |
| 2024 | 30.1% | −69.2% | −12.0% |
| 2025 | −100.0% | 99.9% | 37.4% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 29 Oct 2026)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.